Cleared Traditional

K992749 - ULTRAVIEW WAVEFORM PAGER SYSTEM, MODEL 91841

K992749 is an FDA 510(k) clearance for ULTRAVIEW WAVEFORM PAGER SYSTEM, manufactured by Spacelabs Medical, Inc.. The device is a Class 2 Cardiovascular device with product code MSX cleared through the Traditional 510(k) pathway after a 151-day FDA review.

K992749 · Spacelabs Medical, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2000
Decision
151d
Days
Class 2
Risk

K992749 is an FDA 510(k) clearance for the ULTRAVIEW WAVEFORM PAGER SYSTEM, MODEL 91841. Classified as System, Network And Communication, Physiological Monitors (product code MSX), Class II - Special Controls.

Submitted by Spacelabs Medical, Inc. (Redmond, US). The FDA issued a Cleared decision on January 14, 2000 after a review of 151 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Spacelabs Medical, Inc. devices

FDA 510(k) Submission Details - K992749

510(k) Number K992749 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 16, 1999
Decision Date January 14, 2000
Days to Decision 151 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
26d slower than avg
Panel avg: 125d · This submission: 151d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MSX Device Classification - Class 2, Special Controls

Product Code MSX System, Network And Communication, Physiological Monitors
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MSX System, Network And Communication, Physiological Monitors

All 106
Devices cleared under the same product code (MSX) and FDA review panel - the closest regulatory comparables to K992749.
DATEX-OHMEDA S/5 DEVICE INTERFACING SOLUTION, N-DISXXXX
K012531 · Datex-Ohmeda · Nov 2001
DATEX-OHMEDA NETWORK AND CENTRAL
K000647 · Datex-Ohmeda, Inc. · Jul 2000
IMPACT.WF MOBILE WAVEFORM RECEIVING SYSTEM
K994430 · General Electric Medical Systems Information Techn · Mar 2000
ALARMVIEW SYSTEM
K992848 · Data Critical Corp. · Nov 1999
STATVIEW SYSTEM
K990378 · Data Critical Corp. · Sep 1999
DINAMAP MPS SELECT PORTABLE MONITOR
K982342 · Critikon Company, LLC · Aug 1998